Survodutide

A GLP-1/glucagon dual receptor agonist peptide that appears in metabolic and hepatic research literature.

Survodutide is a synthetic peptide described in the literature as a dual agonist at the GLP-1 and glucagon receptors. As a research material it is handled as a defined multi-receptor peptide and has been the subject of research examining combined receptor signaling and hepatic metabolic pathways. This page is background about the molecule and is not medical guidance or intended for human use.

Classification and structure

Survodutide is classified as a peptide, structurally a single acylated chain designed to engage two distinct receptors in study systems. It carries modifications intended to extend its circulating half-life. It is supplied strictly as a research material.

Areas of research

In the published literature, survodutide appears most often in the following research areas.

• Dual receptor signaling — Investigated in models examining combined GLP-1 and glucagon receptor engagement.
• Hepatic metabolic research — Appears in the literature on liver and metabolic-tissue research models.
• Energy-balance models — Studied in research examining metabolic and energy-expenditure signaling.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Lyophilized survodutide is generally kept cold and dry until reconstitution in the laboratory setting. Every in-stock lot ships with a third-party certificate of analysis that can be verified by its lot number.